{Reference Type}: Review
{Title}: Male Breast Cancer: Three Case Reports and a Literature Review.
{Author}: Xin Y;Wang F;Ren D;Zhao F;Zhao J;
{Journal}: Anticancer Agents Med Chem
{Volume}: 23
{Issue}: 19
{Year}: 2023 Aug 21
{Factor}: 2.527
{DOI}: 10.2174/1871520623666230821124008
{Abstract}: Male breast cancer (MBC) accounts for 0.5%-1% of all breast cancers diagnosed worldwide. However, its biological characteristics can be distinguished from that of female breast cancer (FBC).<BR>The diagnostic and treatment approaches for MBC are mainly similar to that of FBC due to the lack of male breast cancer-related studies, clinical trials, and literature. An increasing number of retrospective and prospective studies have been conducted to clarify the individualized care for MBC. Herein, we report three cases of advanced MBC to describe the diagnostic approaches, treatment process, and survival prognosis.<BR>MBC patients had older age, later stage at first diagnosis, higher expression of hormone receptors, and poor prognosis. A literature review was conducted to determine the incidence, risk factors, disease features, diagnosis, treatment, survival, and management of MBC.